Regulations.gov document
Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act…
Notice · FDA-2024-N-5784 · posted Jan 3, 2025
Key facts
| Document ID | FDA-2024-N-5784-0001 |
|---|---|
| Title | Interested Parties Meeting: Implementation of the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act |
| Document type | Notice |
| Subtype | Request for Comments |
| Agency | FDA |
| Docket | FDA-2024-N-5784 |
| Posted | Jan 3, 2025 |
| Federal Register citation | 90 FR 322 |
| FR document number | 2024-31312 |
| Comment period opens | Jan 3, 2025 |
| Comments due | Oct 1, 2025 |
| Effective date | Jan 3, 2025 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: